72 related articles for article (PubMed ID: 32384455)
1. High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer.
Kang SH; Cho J; Jeong H; Kwon SY
J Breast Cancer; 2018 Sep; 21(3):288-296. PubMed ID: 30275857
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding proteins RBM-HuR, RBM3 and PODXL expression in urothelial carcinoma of the urinary bladder. Prognostic and clinical implications.
Hafez AM; Seleem MM; Alattar AZ; Elshorbagy S; Elsayed WSH
Contemp Oncol (Pozn); 2021; 25(4):279-290. PubMed ID: 35079236
[TBL] [Abstract][Full Text] [Related]
3. The RNA-Binding Motif Protein Family in Cancer: Friend or Foe?
Li Z; Guo Q; Zhang J; Fu Z; Wang Y; Wang T; Tang J
Front Oncol; 2021; 11():757135. PubMed ID: 34804951
[TBL] [Abstract][Full Text] [Related]
4. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
Wang S; Chen X; Qiao T
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
[TBL] [Abstract][Full Text] [Related]
7. The prognostic and clinicopathological significance of RBM3 in the survival of patients with tumor: A Prisma-compliant meta-analysis.
Gao G; Shi X; Long Y; Yao Z; Shen J; Shen L
Medicine (Baltimore); 2020 May; 99(19):e20002. PubMed ID: 32384455
[TBL] [Abstract][Full Text] [Related]
8. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.
Ye F; Jin P; Cai X; Cai P; Cai H
Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314
[TBL] [Abstract][Full Text] [Related]
9. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer.
Salomonsson A; Micke P; Mattsson JSM; La Fleur L; Isaksson J; Jönsson M; Nodin B; Botling J; Uhlén M; Jirström K; Staaf J; Planck M; Brunnström H
Cancer Med; 2020 Aug; 9(15):5609-5619. PubMed ID: 32491279
[TBL] [Abstract][Full Text] [Related]
12. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K
J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469
[TBL] [Abstract][Full Text] [Related]
13. The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production.
Dong W; Dai ZH; Liu FC; Guo XG; Ge CM; Ding J; Liu H; Yang F
EBioMedicine; 2019 Jul; 45():155-167. PubMed ID: 31235426
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers.
Melling N; Bachmann K; Hofmann B; El Gammal AT; Reeh M; Mann O; Moebius C; Blessmann M; Izbicki JR; Grupp K
J Cancer Res Clin Oncol; 2019 Apr; 145(4):873-879. PubMed ID: 30758670
[TBL] [Abstract][Full Text] [Related]
15. RBM3 upregulates ARPC2 by binding the 3'UTR and contributes to breast cancer progression.
Chen P; Yue X; Xiong H; Lu X; Ji Z
Int J Oncol; 2019 Apr; 54(4):1387-1397. PubMed ID: 30720048
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]